SRGAQ — Surgalign Holdings Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.17m
- -$2.01m
- $81.98m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -148.1% | ||
| Return on Equity | -1497.02% | ||
| Operating Margin | -90.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 92.11 | 117.42 | 101.75 | 90.5 | 81.98 | 54.32 | 57.87 | -21.76% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Surgalign Holdings, Inc. is a medical technology company. The Company is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. It has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. It also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.
Directors
- Sheryl Conley NEC
- Terry Rich PRE (53)
- Chris Thunander CAO (37)
- Joshua DeRienzis GCN (52)
- Scott Durall OTH (57)
- Mark Stolper LED (49)
- Pawel Lewicki DRC (67)
- Thomas McEachin IND (68)
- Paul Thomas IND (65)
- Nicholas Valeriani IND (64)
- Last Annual
- December 31st, 2022
- Last Interim
- March 31st, 2023
- Incorporated
- October 26th, 2018
- Public Since
- August 10th, 2000
- No. of Shareholders
- 291
- No. of Employees
- 217
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 9,183,447
- Address
- 520 Lake Cook Rd Ste 315, DEERFIELD, 60015-4926
- Web
- https://www.surgalign.com/
- Phone
- +1 3864188888
- Contact
- Glenn Wiener
- Auditors
- Deloitte & Touche LLP
Upcoming Events for SRGAQ
Q3 2023 Surgalign Holdings Inc Earnings Release
Similar to SRGAQ
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
Agape ATP
Pink Sheets on Nasdaq
FAQ
What is the Surgalign Holdings share price?
As of Today at 01:21 UTC, shares in Surgalign Holdings are trading at $0.04. This share price information is delayed by 15 minutes.
How has the Surgalign Holdings share price performed this year?
Shares in Surgalign Holdings last closed at $0.04 and the price had moved by -98.87% over the past 365 days. In terms of relative price strength the Surgalign Holdings share price has underperformed the S&P500 Index by -99.01% over the past year.
What are the analyst and broker recommendations for Surgalign Holdings?
The overall consensus recommendation for Surgalign Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Surgalign Holdings dividend yield?
Surgalign Holdings does not currently pay a dividend.
Does Surgalign Holdings pay a dividend?
Surgalign Holdings does not currently pay a dividend.
When does Surgalign Holdings next pay dividends?
Surgalign Holdings does not currently pay a dividend.
How do I buy Surgalign Holdings shares?
To buy shares in Surgalign Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Surgalign Holdings?
As of the previous close price of $0.04, shares in Surgalign Holdings had a market capitalisation of $0.28m.
Where are Surgalign Holdings shares listed?
Here are the trading details for Surgalign Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: SRGAQ
What kind of share is Surgalign Holdings?
Based on an overall assessment of its quality, value and momentum Surgalign Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Surgalign Holdings share price forecast for 2023?
The analyst consensus target price for shares in Surgalign Holdings is $2.63. That is 7400% above the last closing price of $0.04.
Analysts covering Surgalign Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$6.30 for the next financial year.
Find out moreWhat is the trend in the Surgalign Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Surgalign Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -98.4%.
As of the last closing price of $0.04, shares in Surgalign Holdings were trading -97.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Surgalign Holdings PE Ratio?
The Surgalign Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Surgalign Holdings?
Surgalign Holdings' management team is headed by:
- Sheryl Conley - NEC
- Terry Rich - PRE
- Chris Thunander - CAO
- Joshua DeRienzis - GCN
- Scott Durall - OTH
- Mark Stolper - LED
- Pawel Lewicki - DRC
- Thomas McEachin - IND
- Paul Thomas - IND
- Nicholas Valeriani - IND